Vermillion Announces Publication of First OVA1® Clinical Utility Study
April 19, 2016 16:01 ET
|
Vermillion, Inc.
AUSTIN, Texas, April 19, 2016 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ:VRML), a bio-analytical solutions company focused on gynecologic disease, today announced the publication of the first...
Vermillion Receives $2 Million Disbursement of up to $4 Million Loan from the Connecticut Department of Economic and Community Development
April 18, 2016 16:01 ET
|
Vermillion, Inc.
AUSTIN, Texas, April 18, 2016 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ:VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that the Company has executed a...